Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ZEBRA TECHNOLOGIES CORPZBRA · Entity 3328 | Chief Financial Officer | May 02, 2026 | May 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ZEBRA TECHNOLOGIES CORP
Report date May 02, 2026 · Filed May 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 25,763 |
Reported balance
After 2026-05-02 transaction · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · 2026-05-02 · Tax withholding · Disposed 717 · Balance 25,763 |
| Class A Common StockSEC Table I · non-derivative | Direct | 23,100 |
Reported balance
After 2026-05-04 transaction · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · 2026-05-04 · Tax withholding · Disposed 2,663 · Balance 23,100 |
| Class A Common StockSEC Table I · non-derivative | Direct | 26,480 |
Reported balance
Holding disclosure · report date 2026-05-02 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 26,480 |
| Stock Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $244.97 · Expires 2027-04-30 | Direct | 578 |
Reported balance
Holding disclosure · report date 2026-05-02 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 578 F1: These stock appreciation rights became exercisable in four equal annual installments beginning on April 30, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: These stock appreciation rights became exercisable in four equal annual installments beginning on April 30, 2021.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 16, 2021 Filed Feb 18, 2021 17:48 UTC | ZEBRA TECHNOLOGIES CORP ZBRA · Entity 3328 | GrantClass A Common Stock | 2,529 | $0.00 | $0.00 |
DisclosureSEC source: 0000877212-21-000022 · wf-form4_161367050674236.xml · nonDerivative · entry 2 Winters Nathan Andrew · CIK 0001823124 · Acting Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,005 F1 · shares: Previously unreportable performance based restricted stock (PVRS) granted May 10, 2018 with a 3-year performance period ended December 31, 2020. Converted to restricted shares as of February 16, 2021 based on performance certification with May 10, 2021 vesting date. Read SEC document |
| November 05, 2020 Filed Nov 24, 2020 14:06 UTC | ZEBRA TECHNOLOGIES CORP ZBRA · Entity 3328 | GrantClass A Common Stock | 456 | $329.18 | $150,106.08 |
DisclosureSEC source: 0000877212-20-000185 · wf-form4_160622679551799.xml · nonDerivative · entry 2 Winters Nathan Andrew · CIK 0001823124 · Acting Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,476 F1 · shares: Of the restricted shares subject to this award, 152 vest on November 5, 2021, 152 vest on November 5, 2022 and 152 vest on November 5, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.